参考文献/References:
[1] 蒋翔宁，陈俊峰，汪勇．血清游离轻链κ/λ 比值联合免疫固定电泳在多发性骨髓瘤患者预后评估中的价值[J]. 中国实验血液学杂志, 2020, 28（1）：191-195． JIANG Xiangning，CHEN Junfeng，WANGYong. Value of serum free light chain kappa/lambdaratio detection combined with immunofixationelectrophoresis in the prognosis evaluation of patientswith multiple myeloma [J]. Journal of ExperimentalHematology, 2020, 28(1): 191-195.
[2] 王得印, 郝云良, 肖萌, 等. 多发性骨髓瘤流行病学及病因分析[J]．国际流行病学传染病学杂志, 2018,45（4）: 277-280． WANG Deyin，HAO Yunliang，XIAO Meng，et al.Epidemiology and etiology of multiple myeloma[J].International Journal of Epidemiology and InfectiousDisease, 2018, 45（4）: 277-280.
[3] 中国医师协会血液科医师分会．中国医学会血液学分会, 中国多发性骨髓瘤工作组. 中国多发性骨髓瘤诊治指南(2017 年修订)[J]. 中华内科杂志, 2017,56（11）: 866-870． Chinese Hematology Association, Chinese Societyof Hematology, Chinese Myeloma Committee-Chinese Hematology Association . The guidelines forthe diagnosis and management of multiple myelomain China (2017 revision) [J]. Chin J Intern Med,2017,56(11): 866-870.
[4] 盘国雄，谭才燕，何嘉颖，等．多发性骨髓瘤患者血清中lncRNA PCAT-1 的表达水平与临床预后研究[J]．现代检验医学杂志, 2018, 33（1）: 72-76． PAN Guoxiong,TAN Caiyan, HE Jiaying, et al. SerumlncRNA PCAT-1 expression level of patients withmultiple myeloma and clinical value[J]. Journal ofModern Laboratory Medicine, 2018, 33(1): 72-76.
[5] WANG Guihua, CAO Xiaonian, LAI Senyan, etal. PI3K stimulates DNA synthesis and cell-cycleprogression via its p55 PIK regulatory subunitinteraction with PCNA[J]. Molecular CancerTherapeutics, 2013, 12(10): 2100-2109.
[6] 杨卫东，王升，赵艳秋，等．IgG 型多发性骨髓瘤化疗后免疫球蛋白重/ 轻链表达及其与预后的关系[J]. 癌症进展，2018, 16（3）: 363-365, 369． YANG Weidong，WANG Sheng，ZHAO Yanqiu，etal. Correlation between the expression of immunoglobulinheavy/light chain ratio after chemotherapy and theprognosis in patients with multiple myeloma of IgGtype[J]. Oncology Progress, 2018, 16(3): 363-365，369.
[7] ZAHARI SHAM S Y, THAMBIAH S C,SAMSUDINI N, et al. Light chain multiple myeloma: an evaluationof its biochemical investigations[J]. The MalaysianJournal of Pathology,2017,39(3): 311-315.
[8] 廖丹，刘霞，李辉军，等．多发性骨髓瘤血、尿总轻链与游离轻链相符率比较及其临床意义[J]. 临床内科杂志，2016，33（4）：243-245． LIAO Dan，LIU Xia，LI Huijun，et al. Thecomparison of accordant rate of total light chains andfree light chains in serum and urine and its clinicalsignificance of muitiple myeloma[J]. Journal of ClinicalInternal Medicine, 2016, 33（4）: 243-245.
[9] 赵丹，姜佳岐，林琳．血清游离轻链及其κ/λ 比率在多发性骨髓瘤患者中的临床意义研究[J]．中国实验血液学杂志, 2019, 27（4）: 1173-1178． ZHAO Dan，JIANG Jiaqi，LIN Lin. Clinical significanceof serum free light chain and its κ/λ ratio inpatients with multiple myeloma[J]. Journal of ExperimentalHematology, 2019, 27(4): 1173-1178.
[10] DEJOIE T, CORRE J, CAILLON H, et al. Responsesin multiple myeloma should be assigned according toserum ,not urine ,free light chain measurements[J].Leukemia, 2019, 33(2): 313-318.